Presentations and conditions
- Adjuncts to transition:
- binding
- hair removal
- tucking
- voice therapy
- Complications of hormone therapy
- Gender dysphoria
- Gender incongruence
- HIV / Sexually transmitted infections (STI) screening and prevention
- Medical transition:
- feminising hormone therapy
- masculinising hormone therapy
- Pelvic pain in people using masculinising hormone therapy
- Reproductive health:
- contraception options
- fertility, including fertility preservation
- pregnancy
- Sexual function and dysfunction
For each presentation and condition, Advanced Trainees will know how to:
Synthesise
- recognise the clinical presentation
- identify relevant epidemiology, prevalence, pathophysiology, and clinical science
- take a comprehensive clinical history
- conduct an appropriate examination
- establish a differential diagnosis
- plan and arrange appropriate investigations
- consider the impact of illness and disease on patients and their quality of life when developing a management plan
Manage
- provide evidence-based management
- prescribe therapies tailored to patients’ needs and conditions
- recognise potential complications of disease and its management, and initiate preventative strategies
- involve multidisciplinary teams
Consider other factors
- identify individual and social factors and the impact of these on diagnosis and management
Presentations and conditions
- Management of gender diverse people aged under 18, and relevant laws
- Mental health issues and neurodivergence in the context of gender diversity
- Neophallus and neovagina:
- assessment of surgical complications
- care / maintenance
- infections
- Social transition
- Surgical options for transition:
- chest augmentation / reconstruction
- gender affirming genital surgery
- other surgery, such as:
- Embryology related to genital development, including intersex variation
- Endocrinology of sexual development and puberty
- Epidemiology of gender diversity in Australia / Aotearoa New Zealand and the limitations of how these statistics are determined
- Pharmacology of hormone therapy:
- expected physical and psychological responses
- initiation protocols
- risks and complications
- risks regarding pregnancy
- side effects
- therapeutic options regarding drug delivery methods
- Spectrum of gender variance, including binary and non-binary gender identities
- Terminology of gender discourse
- Assessment of conditions of the neovagina and neophallus, including:
- differing presentations of common conditions, including infections
- surgical complications
- Baseline investigations prior to gender-affirming hormone therapy
- Interpretation of hormone levels related to gender-affirming therapy
- Monitoring of clients using gender-affirming hormone therapy
- Acknowledge current evidence gaps in management
- Cancer screening
- Intersectionality with sexual health risks
- Legislation affecting social transition
- Legislation regarding transition in children and adolescents
- Local support services, including non-governmental organisations and peer support networks
- Models of consent to gender-affirming care
- Role of mental health practitioners in supporting people accessing gender-affirming care
- Stigma and discrimination
